Cargando…
Neoadjuvant Androgen Receptor Signaling Inhibitors before Radical Prostatectomy for Non-Metastatic Advanced Prostate Cancer: A Systematic Review
(1) Background: Several phase II studies, including randomized controlled trials (RCTs), assessed the efficacy of adding androgen receptor signaling inhibitors (ARSIs) to androgen deprivation therapy (ADT) as a neoadjuvant treatment in patients treated with radical prostatectomy (RP) for prostate ca...
Autores principales: | Yanagisawa, Takafumi, Rajwa, Pawel, Quhal, Fahad, Kawada, Tatsushi, Bekku, Kensuke, Laukhtina, Ekaterina, von Deimling, Markus, Chlosta, Marcin, Karakiewicz, Pierre I., Kimura, Takahiro, Shariat, Shahrokh F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142264/ https://www.ncbi.nlm.nih.gov/pubmed/37109028 http://dx.doi.org/10.3390/jpm13040641 |
Ejemplares similares
-
An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
por: Yanagisawa, Takafumi, et al.
Publicado: (2023) -
Impact of sex on the efficacy of immune checkpoint inhibitors in kidney and urothelial cancers: a systematic review and meta-analysis
por: Yanagisawa, Takafumi, et al.
Publicado: (2023) -
Role of lymphadenectomy during primary surgery for kidney cancer
por: Bekku, Kensuke, et al.
Publicado: (2023) -
Need for and extent of lymph node dissection for upper tract urothelial carcinoma: an updated review in 2023
por: Yanagisawa, Takafumi, et al.
Publicado: (2023) -
Role of systemic immune-inflammation index in patients treated with salvage radical prostatectomy
por: Rajwa, Pawel, et al.
Publicado: (2021)